Deltex launches new system in UK, EU markets
(Sharecast News) - Oesophageal monitoring technology specialist Deltex Medical Group announced the launch of its next-generation 'TrueVue' system in the UK and the EU on Monday.
Read moreWed, 03rd Jun 2020 09:49
(Sharecast News) - Oesophageal monitoring technology specialist Deltex Medical Group announced the launch of its next-generation 'TrueVue' system in the UK and the EU on Monday.
Read more(Alliance News) - Deltex Medical Group PLC said it will launch its next generation TrueVue measurement for blood pressure and blood flow in November this year.
Read more(Sharecast News) - Oesophageal monitoring specialist Deltex Medical Group reported unaudited first-half revenues of £1.1m on Thursday - slightly lower than the £1.2m generated in the same period last year.
Read moreDeltex Medical Group PLC - Chichester, England-based blood circulation monitoring system maker - Warns it may need to conduct an equity fundraise, which would be at a "material discount" to its current share price. If it goes ahead, the equity raise would include a retail offer. In the absence of a funding solution, Deltex is "highly likely" to appoint an administrator, it says.
Read more(Alliance News) - Deltex Medical Group PLC on Monday said that its shares have been suspended from trading on AIM, pending clarification on its financial position.
Read moreDeltex Medical Group PLC - Chichester, England-based cardiac monitoring system maker - Reports good progress towards finalising its new, next generation monitor, including completing the necessary regulatory documentation required for its launch. Intends to launch this new product in June 2023 initially in the UK and EU markets. Will then seek regulatory approval for launch into other key global markets over the next 6-18 months. In addition, continues to maximise revenues from the current generation monitor and probes via its direct sales teams in the UK and US whilst simultaneously preparing the market for the launch of the new, next generation monitor.
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
Read more(Alliance News) - Deltex Medical Group PLC said on Thursday its pretax loss widened amid impairment expenses while rise in monitor sales drove annual revenue.
Read moreDeltex Medical Group PLC - Chichester-based cardiac monitoring system maker - Extends deadline for repayment of GBP1.1 million convertible loan notes in the company to June 30, 2026 from February 26, 2024. Says all other terms of the loan notes, issued in February 2016, remained unchanged. Says they remain unsecured, carrying an annual interest rate of 8% and convertible into new shares at a price of 4.00 pence per share at any time until the repayment date at the discretion of the lender.
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
Read more(Sharecast News) - Esophageal monitoring technology company Deltex Medical Group announced on Friday that its year-to-date revenues were ahead of its full-year 2021 figures.
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
Read more(Alliance News) - Deltex Medical Group PLC on Tuesday posted a widened loss in the first half of 2022 but said it expects strong demand from customers aiming to replace legacy monitors in the near future.
Read more(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.
Read more(Alliance News) - Deltex Medical Group PLC on Thursday said that revenue was up in the first half of the year, however its performance remains constrained by Covid-19 restrictions.
Read more